New research highlights progress in treating age-related macular degeneration, including late‑stage drug trials, gene therapy strategies, and a wireless retinal prosthesis that restored limited ...
COLUMBUS – Prevent Blindness Ohio is declaring February as Age-related Macular Degeneration and Low Vision Month in an effort to provide education and various expert-approved resources to the public ...
The risk for neovascular age-related macular degeneration (nAMD) seems not to be increased following cataract surgery, ...
Hosted on MSN
Could AI Transform AMD Care? Experts Say Yes
Artificial intelligence (AI) is on the cusp of transforming how age-related macular degeneration (AMD) is diagnosed, monitored, and treated both in the medical office and at home, specialists say.
Distributors of Cancer Drug Probed After Patients Go Blind Pakistan is investigating two local distributors of Avastin after 12 patients with diabetes injected with the drug went blind. Reuters Health ...
Age-related macular degeneration (AMD) is the nation's leading cause of blindness in older adults, outpacing even glaucoma and cataracts, and nearly 1% of Americans age 40 and older have ...
The Phenocell-Amarna collaboration aims to assess a groundbreaking gene therapy approach for Dry AMD based on Amarna’s SV40-derived Nimvec™ gene delivery vector platform combined with Phenocell’s ...
Aflibercept 8 mg Promising Alternative to 2 mg for PCV Aflibercept 8 mg provides similar outcomes for vision and eye structure as the 2-mg dose in patients with polypoidal choroidal vasculopathy, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results